Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology | Psychiatry/Psychology | Obstetrics/Gynecology | Endocrinology
Disease Category: Sexual Dysfunction
Trial Information
Study to evaluate whether a change in medication will lessen the sexual side effects caused by many antidepressants
The purpose of this research is to get information on the
effectiveness of switching to duloxetine (Cymbalta) from a
selective serotonin reuptake inhibitor (SSRI) to relieve sexual
dysfunction in patients with depression. Duloxetine has been
approved by the federal Food and Drug Administration for the
treatment of depression. Some research evidence indicates that
sexual side effects are less likely with duloxetine than with some
other antidepressants, including SSRIs.
This research study will require 10 visits to the Stanford
Psychiatry Clinic across 13 weeks. At each visit participants will
be interviewed about their symptoms of depression or dysthymia and
about their sexual function, and their heart rate, blood pressure,
and weight will be obtained.
Patient Inclusion Criteria
- Adult age 18 or over
- Able to come to Stanford weekly
- Currently being treated with an SSRI for depression or
dysthymia
- Suffering from sexual dysfunction related to the SSRI
Patient Exclusion Criteria
- Suffering from a medical disorder or taking a medicaion that
could be the cause of the sexual dysfunction
- Need ongoing treatment with a mood stabilizer or
antipsychotic
Nona Gamel, Clinical Research Manager
Stanford University School of Medicine
401 Quarry Road
Stanford, CA 94301-5721
Phone: 650-725-5180
EMail: gamel05@stanford.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
